Centocor, Inc. - CNTO- Profile

Centocor, Inc. is a biopharmaceutical company which develops and commercializes novel therapeutic and diagnostic products and services. The company primarily focuses on monoclonal antibodies and DNA-based products for healthcare needs. Centocor develops products for infectious, cardiovascular disease and cancer. The company's products include ReoPro - used in the treatment of cardiovascular disease to prevent blood clots, Avakine - used in the treatment of rheumatoid arthritis and inflammatory bowel diseases such as Crohn's disease and Panorex - a monoclonal antibody that targets metastatic colon cancer cells. The in-vitro diagnostic products are used to test patient blood samples outside the body to detect or monitor disease. The diagnostic products of the company include pancreatic cancer test, breast cancer test, gastric cancer test and non-small cell lung cancer test. The company acquired Retavase in 1998. The company has international operations in Europe and other foreign countries. International operations accounted for 15% of 1998 revenues. Pharmaceutical products accounted for 92% of 1998 revenues and diagnostics, 8%.